Infusion site induration: Which Medications Cause It? (1,140 Reports Across 39 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Infusion site induration has been reported as an adverse event with 39 different drugs in the FDA's FAERS database, with 1,140 total reports. 20 of these reports resulted in death.The drugs most commonly associated with Infusion site induration are TREPROSTINIL, HUMAN IMMUNOGLOBULIN G, and FOSCARBIDOPA\FOSLEVODOPA.
1,140
Total Reports
39
Drugs Involved
20
Deaths
279
Hospitalizations
53.4 yrs
Average Patient Age
74.3% / 25.7%
Female / Male
Which Drugs Cause Infusion site induration Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| TREPROSTINIL | 598 | 0.7% | 11 | 118 | 6 |
| HUMAN IMMUNOGLOBULIN G | 209 | 0.3% | 3 | 36 | 2 |
| FOSCARBIDOPA\FOSLEVODOPA | 112 | 3.5% | 4 | 74 | 2 |
| AMBRISENTAN | 49 | 0.1% | 0 | 9 | 0 |
| MACITENTAN | 26 | 0.1% | 0 | 10 | 0 |
| HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN | 25 | 0.6% | 0 | 3 | 0 |
| CAPECITABINE | 23 | 0.0% | 0 | 0 | 0 |
| EVEROLIMUS | 22 | 0.1% | 0 | 0 | 0 |
| ZOLEDRONIC ACID | 22 | 0.1% | 0 | 0 | 0 |
| PAMIDRONATE | 20 | 1.2% | 0 | 0 | 0 |
| HUMAN IMMUNOGLOBULIN G\HYALURONIDASE | 17 | 0.6% | 0 | 5 | 0 |
| TADALAFIL | 17 | 0.1% | 0 | 6 | 0 |
| INSULIN LISPRO-AABC | 16 | 2.0% | 0 | 0 | 0 |
| INFLIXIMAB-DYYB | 14 | 0.1% | 0 | 4 | 0 |
| LECITHIN\POLOXAMER 407 | 14 | 8.1% | 0 | 4 | 0 |
| CARBIDOPA\LEVODOPA | 12 | 0.0% | 1 | 6 | 0 |
| ACETAMINOPHEN | 11 | 0.0% | 0 | 1 | 0 |
| INFLIXIMAB | 10 | 0.0% | 0 | 2 | 0 |
| WARFARIN | 10 | 0.0% | 1 | 1 | 0 |
| SELEXIPAG | 9 | 0.1% | 1 | 3 | 0 |